Alcohol Addiction – Global Clinical Trials Review, 2022
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The alcohol addiction clinical trial report provides a comprehensive overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on number of ongoing trials).
What are the market dynamics in the alcohol addiction clinical trials market?
Alcohol addiction clinical trial report consists of more than 800 trials. Trials conducted by companies are in Phase IV, Phase III, Phase II, Phase I and Phase 0. Similarly, the trials with different status compile of completed, ongoing, planned, suspended, terminated and withdrawn.
Which are the key regions in the alcohol addiction clinical trials market?
The key regions in the alcohol addiction clinical trials market are Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America.
Alcohol addiction clinical trials market in Asia-Pacific
The top five countries in Asia-Pacific in the alcohol addiction clinical trials market are China, South Korea, India, Australia, and Japan. Australia has the highest number of clinical trials, followed by India, China, Japan, and South Korea.
Alcohol addiction clinical trials market in Europe
The top five countries in Europe in the alcohol addiction clinical trials market are Russia, Germany, the United Kingdom, Spain, and France. Germany has the highest number of clinical trials, followed by France, Russia, the UK, and Spain.
Alcohol addiction clinical trials market in North America
The top two countries in North America in the alcohol addiction clinical trials market are the US and Canada. The US has the highest number of clinical trials followed by Canada.
Alcohol addiction clinical trials market in the Middle East & Africa
The top five countries in the Middle East & Africa in the alcohol addiction clinical trials market are Iran, Israel, Lebanon, South Africa, and Uganda. Iran has the highest number of clinical trials, followed by Israel, Lebanon, South Africa, and Uganda.
Alcohol addiction clinical trials market in South & Central America
The top two countries in South & Central America in the alcohol addiction clinical trials market are Brazil and Peru. Brazil has the highest number of clinical trials followed by Peru.
Alcohol addiction clinical trials market in G7 countries
The G7 countries in the alcohol addiction clinical trials market include the US, the UK, Germany, France, Italy, Canada and Japan. The US have the highest number of alcohol addiction clinical trials as of February 2022
Alcohol addiction clinical trials market in E7 countries
The E7 countries in the alcohol addiction clinical trials market include Brazil, Russia, India, China, Mexico, Turkey and Indonesia. Russia has the highest number of alcohol addiction clinical trials as of February 2022.
Alcohol addiction clinical trial market, by key region
For more regional insights, download a free sample
Which are the key sponsors in the alcohol addiction clinical trials market?
The key sponsors in the alcohol addiction clinical trials market are Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc.
Alcohol addiction clinical trial market, by key sponsors
To know more about key sponsors, download a free sample
Market report scope
Key regions | Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America |
Key phases | Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0 |
Key sponsors | Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc. |
Scope
- The report provides a snapshot of the global clinical trials landscape.
- Report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end point status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for failure.
- The report provides enrollment trends for the past five years.
- Report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
The Lundbeck Foundation
Pfizer Inc
Eli Lilly and Co
Johnson & Johnson
AstraZeneca Plc
GlaxoSmithKline Plc
Indivior Plc
Merck & Co Inc
Otsuka Holdings Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the alcohol addiction clinical trials market?
Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America are the key regions in the alcohol addiction clinical trials market.
-
What are the key phases in the alcohol addiction clinical trials market?
The key phases in the alcohol addiction clinical trials market are Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0.
-
Who are the key sponsors in the alcohol addiction clinical trials market?
Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc. are the key sponsors in the alcohol addiction clinical trials market.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.